JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 1, 2005; DOI: 10.1124/jpet.104.080721


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.080721v1
313/2/751    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuan, Y.
Right arrow Articles by Atchison, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuan, Y.
Right arrow Articles by Atchison, W. D.


Received for publication November 18, 2004.
Revised January 31, 2005.
Accepted for publication January 31, 2005.

Methylmercury Induces a Spontaneous, Transient Slow Inward Chloride Current in Purkinje Cells of Rat Cerebellar Slices

Yukun Yuan 1 William D. Atchison 1*

1 Michigan State University

* Address correspondence to: E-mail: atchiso1{at}msu.edu

Abstract

Methylmercury (MeHg, 10 - 100 µM) induced a spontaneous, transient, slow inward current in Purkinje cells in rat cerebellar slices. Insensitivity of this current to tetrodotoxin suggests that its generation is not related to presynaptic firing. The present study was designed to attempt to identify the ionic origin of this current. Neither Gd3+, a nonspecific cation channel blocker, nor tetrakis(2-pyridylmethyl)ethylethylenediamine which chelates Zn2+, could prevent this current. Following dialysis of cells with a low [Cl-] pipette solution, the giant currents were inducible only when the cells were held at potentials more positive than 0 mV, but not at potentials more negative than -60 mV. Also, no giant currents were observed when cells were held at 0 mV under symmetrical [Cl-] conditions. Thus, this current appears to be mediated by Cl-. However, it was insensitive to the glycine receptor antagonist strychnine. The anion channel blockers 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) or niflumic acid suppressed GABAA receptor-mediated spontaneous inhibitory postsynaptic currents. Niflumic acid also prevented appearance of this giant current; DIDS was only effective at more positive membrane potentials. Thus, this current appears to be carried by a voltage-dependent Cl- channel. Reducing extracellular Ca2+ concentration and/or intracellular application of the Ca2+ chelator BAPTA appeared to be ineffective at preventing appearance of this current. Thus, these data do not appear to support the conclusion that this current is mediated by a Ca2+-activated Cl- channel. The role which this current plays in MeHg-induced neurotoxicity is unknown.


Key words: brain slice, cerebellar dysfunction, methylmercury-induced, cerebellum, chloride channel current, methylmercury, neurotoxicity, methylmercury-induced


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
Y. Yuan and W. D. Atchison
Methylmercury-Induced Increase of Intracellular Ca2+ Increases Spontaneous Synaptic Current Frequency in Rat Cerebellar Slices
Mol. Pharmacol., April 1, 2007; 71(4): 1109 - 1121.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Tarabova, M. Kurejova, Z. Sulova, M. Drabova, and L. Lacinova
Inorganic Mercury and Methylmercury Inhibit the Cav3.1 Channel Expressed in Human Embryonic Kidney 293 Cells by Different Mechanisms
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 418 - 427.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.